• العربية
    • English
  • English 
    • العربية
    • English
  • Login
Home
Publisher PoliciesTerms of InterestHelp Videos
Submit Thesis
IntroductionIUGSpace Policies
JavaScript is disabled for your browser. Some features of this site may not work without it.
View Item 
  •   Home
  • Faculty of Health Science
  • Staff Publications- Faculty of Health Sciences
  • View Item
  •   Home
  • Faculty of Health Science
  • Staff Publications- Faculty of Health Sciences
  • View Item

Please use this identifier to cite or link to this item:

http://hdl.handle.net/20.500.12358/28615
TitleCompliance Amongst Warfarin Users Diagnosed Non-valvular Atrial Fibrillation are We Aware: Prospective Survey
Title in Arabicدراسة استقصائية لمدى التزام المرضى المشخصين رجفان أذيني غير صمامي المستخدمين لدواء وارفارين
Abstract

Introduction: Vitamin k antagonists are the most commonly prescribed anticoagulation among non-valvular atrial fibrillation patients. It is indicated for stroke prevention in this group of patients. The aim of this study is to assess patient compliance among NVAF warfarin users. Method: The study designed as prospective study, conducted in the medical department in Indonesian and Shifa hospital- Palestine. We included patients undergoing oral anticoagulation with VKA diagnosed with NVAF with diabetes, cardiovascular disease aged between 20-85 years old, otherwise were excluded. The laboratory data include the INR, creatinine clearance, random blood sugar, systolic and diastolic blood pressure, liver chemistry extracted from patient file. Analysis: Continuous data are presented as the mean ± standard deviation, and the categoric variables were presented as percentage. To find the relationship between quantitative variables we used binary univariate analysis statistically significant results were considered at a two-tailed p-value <0.05. Data were analyzed using SPSS version 20 software. Finding: The total number was 100 patients, 50% males and the remain females. The results show that 43% of the patients know the risk of the drug while 39% know about the benefit. Only 58% of patients are within the therapeutic INR and 66% do not follow regular INR monitoring. There was 28% of patients are not in contact with any health care providers for drug monitoring. The results also show that 21% of patients do not follow their daily dose and 36% complain of hemorrhage. The results clarify that there exists a positive relationship between a creatinine, diastolic Bp, systolic Bp and INR Since p-value <0.05. Interpretation: The finding of this study shows that most of our patients' unaware warfarin, so we recommend construction of warfarin clinic for this group of patients for regular follow up with education program with qualified health care provider.

Authors
Mansour, Hashem
Lubbad, Rafat
Aboobaid, Hasan
Issi, Khamis
TypeOther
Date2019-03-29
LanguageEnglish
Subjects
Warfarin
Anticoagulation
Bleeding
Published inCardiovascular Pharmacology
SeriesVol. 08, No. 02
PublisherLongdom Group
Citation
Item linkItem Link
DOI10.35248/2329-6607.19.8.252
License
Collections
  • Staff Publications- Faculty of Health Sciences [192]
Files in this item
compliance-amongst-warfarin-users-diagnosed-nonvalvular-atrial-fibrillation-are-we-aware-prospective-survey.pdf208.5Kb
Thumbnail

The institutional repository of the Islamic University of Gaza was established as part of the ROMOR project that has been co-funded with support from the European Commission under the ERASMUS + European programme. This publication reflects the views only of the author, and the Commission cannot be held responsible for any use which may be made of the information contained therein.

Contact Us | Send Feedback
 

 

Browse

All of IUGSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsSupervisorsThis CollectionBy Issue DateAuthorsTitlesSubjectsSupervisors

My Account

LoginRegister

Statistics

View Usage Statistics

The institutional repository of the Islamic University of Gaza was established as part of the ROMOR project that has been co-funded with support from the European Commission under the ERASMUS + European programme. This publication reflects the views only of the author, and the Commission cannot be held responsible for any use which may be made of the information contained therein.

Contact Us | Send Feedback